Autopsy report · NCT02506114

Neoadjuvant PROSTVAC-VF With or Without Ipilimumab for Prostate Cancer

“Low Accrual”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 3 months before it started.
• Ran for about 3 years 7 months before it stopped.
• 15 participants enrolled.
• Results were posted on the registry 1 year 7 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Lawrence Fong

Sponsor type

University, hospital or other

Conditions

Prostatic Neoplasms

Interventions

PROSTVAC V/F; Ipilimumab

Participants

15

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.